News
StockStory.org on MSN3h
The Top 5 Analyst Questions From First BanCorp’s Q2 Earnings CallFirst BanCorp’s second quarter results received a negative market reaction, as revenue growth missed Wall Street’s ...
Spotify (NYSE:SPOT) stock drops 5.5% after Q2 earnings miss and weak Q3 forecast. Discover key insights on revenue, user ...
StockStory.org on MSN57m
D.R. Horton’s Q2 Earnings Call: Our Top 5 Analyst QuestionsD.R. Horton’s second quarter results were well received by the market as the company exceeded Wall Street’s revenue and ...
Microsoft's growth is driven by Copilot adoption, margin expansion, and strong earnings. Click to read more about a key ...
Cadence Design Systems reported second-quarter revenue of $1.28 billion, beating analyst estimates of $1.26 billion. The ...
In addition to Wells Fargo, EQT also received a Buy from TR | OpenAI – 4o’s Grant Digwell in a report issued on July 25. However, on the same day, Piper Sandler maintained a Hold rating on EQT (NYSE: ...
6h
TipRanks on MSNHubbell reports Q2 adjusted EPS $4.93, consensus $4.40Reports Q2 revenue $1.484B, consensus $1.51B. “Hubbell (HUBB) delivered double digit adjusted earnings per share growth in the second quarter, ...
RBC Capital analyst Gregory Pardy maintained a Hold rating on Ovintiv on July 25 and set a price target of $55.00. The company’s shares closed last Friday at $41.43. Take advantage of TipRanks Premium ...
The Federal Reserve announces interest rates on Wednesday after the arrival of advance estimates of second-quarter U.S. gross ...
SunPower (aka Complete Solaria, Inc.) ('SunPower” or the 'Company”) (Nasdaq: SPWR), a solar technology, services, and installation company, today announced the Company will attend the Canaccord ...
8h
TipRanks on MSNStanley Black & Decker raises FY25 adjusted EPS view to $4.65 from $4.50Consensus $4.48. The company said, “The Company will review its planning scenario, including the current estimated tariff impact net of price and ...
VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results